Observational Study of Intranasal Insulin Delivery in Autism Spectrum Disorder Ages 4 to 21 Years (INS-AUT)

Observational Study of Intranasal Insulin Delivery in Autism Spectrum Disorder Ages 4 to 21 Years (INS-AUT)

Publication date: Apr 03, 2026

Concepts Keywords
Autism ASD
Fda ASD observational
Healthcare autism children insulin
Insulin autism spectrum disorder
Investigator brain insulin signaling
controlled particle dispersion
CPD nasal device
developmental delay insulin
intranasal delivery autism
intranasal insulin
intranasal insulin autism
Kurve nasal device
nasal spray autism
neurodevelopmental
neurodevelopmental disorders
nose-to-brain delivery
observational cohort
off-label
pediatric autism
real-world evidence
repetitive behaviors autism
social communication autism

Semantics

Type Source Name
disease MESH Autism Spectrum Disorder
pathway REACTOME Metabolism
disease MESH autism
drug DRUGBANK Tropicamide
disease MESH diabetes mellitus
disease MESH hypersensitivity
disease MESH Adolescents|Neurodevelopmental

Original Article

(Visited 6 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *